Founded
Address
ARCH Venture Partners
1700 Owens Street
Suite 535
San Francisco, CA 94158
United States
Phone
Website
Industry
Recent investment activity
KANDO id: 30599
Corporate information
Official name
ARCH Venture Partners LP
Registration country
Official identities
US CIK 0001666306
Company type
Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startupFunds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| ARCH Venture Fund IX LP | Venture | 2016 | USD | 550,000,000 |
| ARCH Venture Fund VIII Overage LP | Venture | 2015 | ||
| ARCH Venture Fund VIII Overage LP | Venture | 2015 | USD | 150,000,000 |
| ARCH Venture Fund VIII LP | Venture | 2014 | USD | 400,532,000 |
| ARCH Venture Fund VII LP | Venture | 2007 | ||
| ARCH Venture Fund VI LP | Venture | 2003 | ||
| ARCH Venture Fund V LP | Venture | 2000 | ||
| ARCH Venture Partners IV | Venture | 1999 | USD | 175,000,000 |
| ARCH Venture Partners III | Venture | 1997 | USD | 107,000,000 |
| ARCH Venture Partners II | Venture | 1993 |
Funding rounds
| Investor | Profile | Country | |
|---|---|---|---|
|
Chevron Technology Ventures LLC | Corporate venturing subsidiary of ChevronTexaco, focusing on the commercialisation and integration of emerging technologies within Chevron |
Investment activity status
Active investor
Selected investments
Displaying 1 - 20 of 134| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_company.png?itok=-3VkoHwg){kind=icon}
|
Acylin Therapeutics Inc | N/A | ||||
|
|
Adolor Corp | N/A | ||||
|
|
Agios Pharmaceuticals Inc | N/A | ||||
|
|
Ahura Scientific Inc | N/A | ||||
|
|
ALIS Corp | N/A | ||||
|
|
Alnylam Pharmaceuticals Inc | N/A | ||||
|
|
Apoptos Inc | N/A | ||||
|
|
Apropos Technology Inc | N/A | ||||
|
|
Artificial Muscle Inc | N/A | ||||
|
|
Aveso Inc | N/A | ||||
|
|
Bluebird Bio Inc | Developer of an innovative gene therapies for severe genetic disorders | Venture | |||
|
|
Bluebird Bio Inc | Developer of an innovative gene therapies for severe genetic disorders | Series D | |||
|
|
Caliper Life Sciences Inc | N/A | ||||
|
|
Callisto Software Inc | N/A | ||||
|
|
Celebrate Express Inc | N/A | ||||
|
|
Celula Inc | N/A | ||||
|
|
CEPTYR Inc | N/A | ||||
|
|
Chiasma Corp | Series C | ||||
|
|
Ciespace Corp | Series A | ||||
|
|
Classmates Media Corp | N/A |
Current employees
| Employee | Position | ||
|---|---|---|---|
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/_person_0.png?itok=nkWWtsDD){kind=icon}
|
Clinton Bybee (founder) | ||
|
|
Keith Crandell (founder) | ||
|
|
Robert Nelsen (founder) | ||
|
|
Kristina Burow | ||
|
|
David Cruikshank | ||
|
|
Steven Gillis | ||
|
|
Edgar Hotard | ||
|
|
Paul Thurk |